Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.00
Bid: 70.00
Ask: 80.00
Change: -2.50 (-3.23%)
Spread: 10.00 (14.286%)
Open: 77.50
High: 77.50
Low: 75.00
Prev. Close: 77.50
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's Remuneration and Consultancy agreement

28 Mar 2013 07:10

RNS Number : 0769B
Biome Technologies PLC
28 March 2013
 



28 March 2013

 

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Director's Remuneration and Consultancy Agreement

 

 

Biome Technologies plc announces that it has agreed with John Standen, Non Executive Chairman of the Company, a change to his remuneration arrangements.

 

From 1 March 2013 for a period of one year, Mr Standen's annual remuneration will reduce from the previous level of £38,250 to £18,000. All other terms and conditions of Mr Standen's contract of employment will remain unchanged.

 

This change is one of a number of measures the Company is undertaking in order to ensure that cash outgoings are minimised.

 

Biome also announces that it has entered into a consultancy agreement with Leapacross Ltd, a company of which John Standen is a director and the majority shareholder (the "Consultancy Agreement"). Under the terms of the Consultancy Agreement, Leapacross will provide strategic consultancy advice to the Company with regard to an assessment of the corporate strategy of Biome following the sale of the Biotec business and in light of the various growth paths available to the Company.

 

The Consultancy Agreement will be in place for the period commencing 2 April 2013 and will terminate no later than 31 October 2013. Payment for the services to be provided under the Consultancy Agreement will be a maximum of £28,000. This sum will be payable in three stages, being £8,000 on commencement of the Consultancy Agreement, £10,000 on 30 June 2013 and £10,000 on 31 October 2013, the latter two payments being subject to, inter alia, satisfactory performance of the Consultancy Agreement.

 

Biome and Leapacross Ltd have agreed that payments due under the Consultancy Agreement will be used to purchase ordinary shares in the Company at the prevailing market value from Channel House Trustees Limited as trustee of the Biome Technologies Plc Employee Benefit Trust as soon as reasonably practical after payment is due.

 

 

- Ends -

 

 

For further information please contact:

 

Biome Technologies plc

Tel: +44 (0) 2380 867 100

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com

 

Daniel Stewart & Company

Tel: +44 (0) 20 7776 6550

David Hart

www.danielstewart.co.uk

 

First Columbus

Tel: +44 (0) 20 3002 2070

Chris Crawford/Kelly Gardiner

www.first-columbus.com

 

FTI Consulting

Tel: +44 (0) 20 7831 3113

Oliver Winters/ Latika Shah

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGZFLNLGFZM
Date   Source Headline
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022
18th Apr 202310:49 amRNSCompletion of CLN Fundraising
17th Apr 202311:30 amRNSResult of General Meeting
31st Mar 202311:14 amRNSProposed issue of Convertible Loan Notes
25th Jan 20237:00 amRNSTrading Update
16th Nov 20227:00 amRNSBiome receives £282k grant
10th Nov 202211:05 amRNSSecond Price Monitoring Extn
10th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTrading Update
18th Oct 20229:28 amRNSHolding(s) in Company
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
5th Sep 20227:00 amRNSGrant funding from Innovate UK
2nd Aug 20228:59 amRNSTrading Update - Replacement
2nd Aug 20227:00 amRNSTrading Update
20th Apr 202212:01 pmRNSResult of Annual General Meeting
20th Apr 20227:00 amRNSTrading Update
30th Mar 20222:48 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSNotice of AGM and 2021 Annual Report
24th Mar 20227:00 amRNSFinal Results 2021
27th Jan 20227:00 amRNSTrading Update
4th Jan 202210:33 amRNSFurther substantial contract win for RF Division
16th Dec 20218:41 amRNSContract
17th Nov 20217:00 amRNSTrading Update
9th Nov 202111:12 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSUpdate re biodegradable tree shelters
15th Sep 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.